Cargando…

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma

Background: Ubiquitination is medicated by three classes of enzymes and has been proven to involve in multiple cancer biological processes. Moreover, dysregulation of ubiquitination has received a growing body of attention in osteosarcoma (OS) tumorigenesis and treatment. Therefore, our study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Nan, Chao-yang, Gong, Wen-ming, Zhou, Ze-yuan, Lei, Yong-qiang, Shi, Shun-bai, Zhang, Kai, Zhang, Yan-chao, Ma, Hai-hong, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428517/ https://www.ncbi.nlm.nih.gov/pubmed/36060009 http://dx.doi.org/10.3389/fphar.2022.904448

Ejemplares similares

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
por: Yang, Jinpo, et al.
Publicado: (2022)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)

Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes
por: Dong, Chunli, et al.
Publicado: (2022)

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
por: Zhang, Jianxiang, et al.
Publicado: (2023)

Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes
por: Wang, Hanyu, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
por: Li, Mingzhe, et al.
Publicado: (2022)

Cancer-associated fibroblast infiltration in osteosarcoma: the discrepancy in subtypes pathways and immunosuppression
por: Zhihao, Zhang, et al.
Publicado: (2023)

Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance
por: Zhang, Wei, et al.
Publicado: (2023)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
por: Li, Yue, et al.
Publicado: (2023)

LncRNA LINC00588 Suppresses the Progression of Osteosarcoma by Acting as a ceRNA for miRNA-1972
por: Zhou, Fu-Chao, et al.
Publicado: (2020)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Development and validation of apoptosis‐related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients
por: Hong, Jinjiong, et al.
Publicado: (2022)

Prognostic Signatures of Metabolic Genes and Metabolism-Related Long Non-coding RNAs Accurately Predict Overall Survival for Osteosarcoma Patients
por: Chao-yang, Gong, et al.
Publicado: (2021)

Constructing a molecular subtype model of colon cancer using machine learning
por: Zhou, Bo, et al.
Publicado: (2022)

Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes
por: Vriend, Jerry, et al.
Publicado: (2022)

Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients
por: Han, Tao, et al.
Publicado: (2023)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

The Ion Channel-Related Gene Signatures Correlated With Diagnosis, Prognosis, and Individualized Treatment in Patients With Clear Cell Renal Cell Carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

Immune-Associated Gene Signatures and Subtypes to Predict the Progression of Atherosclerotic Plaques Based on Machine Learning
por: Yang, Yujia, et al.
Publicado: (2022)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions
por: Tang, Jinxin, et al.
Publicado: (2022)

The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
por: Zhou, Tao, et al.
Publicado: (2022)

Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
por: Wang, Chengcheng, et al.
Publicado: (2023)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma
por: Chen, Ji, et al.
Publicado: (2022)

Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer
por: Song, Guoda, et al.
Publicado: (2022)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Analysis of Immune–Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment
por: Zheng, Dingzhao, et al.
Publicado: (2021)

Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients
por: Wan, Yue, et al.
Publicado: (2021)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
por: Li, Jixian, et al.
Publicado: (2023)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness
por: Tu, Sheng, et al.
Publicado: (2023)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hfhpvnio3gb2elsd1l447opiim